Literature DB >> 10801801

Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction.

K Breitschopf1, A M Zeiher, S Dimmeler.   

Abstract

Under basal conditions, the proapoptotic protein Bid is a long-lived protein. Pro-apoptotic stimuli such as tumor necrosis factor-alpha (TNFalpha) or Fas induce its caspase-8-mediated cleavage into two fragments. The COOH-terminal cleavage fragment of Bid (tBid) becomes localized to mitochondrial membranes and triggers the release of cytochrome c. Here we show that tBid is ubiquitinated and subsequently degraded by the 26 S proteasome. Degradation of tBid is significantly inhibited by the proteasome inhibitors MG-132 and lactacystin. In contrast, caspase-specific or lysosomal inhibitors do not affect tBid stability. Furthermore, mutation of the putative ubiquitin acceptor sites within tBid results in a stabilized protein as assessed by pulse-chase analysis. To address whether tBid degradation might be regulated by interaction with other Bcl-2-like proteins, cotransfection studies were performed. However, neither the presence of proapoptotic Bax nor antiapoptotic Bcl-2 or Bcl-XL affected tBid degradation. Finally, we determined the functional role of tBid degradation. Overexpression of stabilized tBid proteins significantly enhanced cytochrome c release and subsequent apoptosis induction approximately 2-fold compared with wild type tBid. Similarly, tBid-induced apoptosis was considerably amplified by inhibition of tBid degradation using the proteasome-specific inhibitor MG-132. Thus, proteasomal degradation of tBid limits the extent of apoptosis in living cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801801     DOI: 10.1074/jbc.M001083200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.

Authors:  Katarina Wikström; Maria Juhas; Anita Sjölander
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 2.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

3.  Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.

Authors:  Robert Meller; Jennifer Anastasia Cameron; Daniel John Torrey; Corrin Erin Clayton; Andrea Nicole Ordonez; David Clifford Henshall; Manabu Minami; Clara Kay Schindler; Julie Anne Saugstad; Roger Pancoast Simon
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

4.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

Review 5.  Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.

Authors:  Kyung Bo Kim; Craig M Crews
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

Review 6.  Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase.

Authors:  Christopher C Franklin; Donald S Backos; Isaac Mohar; Collin C White; Henry J Forman; Terrance J Kavanagh
Journal:  Mol Aspects Med       Date:  2008-09-06

7.  Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim.

Authors:  Toru Akiyama; Phillippe Bouillet; Tsuyoshi Miyazaki; Yuho Kadono; Hirotaka Chikuda; Ung-Il Chung; Akira Fukuda; Atsuhiko Hikita; Hiroaki Seto; Takashi Okada; Toshiya Inaba; Archana Sanjay; Roland Baron; Hiroshi Kawaguchi; Hiromi Oda; Kozo Nakamura; Andreas Strasser; Sakae Tanaka
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 8.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

9.  Unregulated ARF6 activation in epithelial cysts generates hyperactive signaling endosomes and disrupts morphogenesis.

Authors:  Jogender S Tushir; James Clancy; Andrew Warren; Carolyn Wrobel; Joan S Brugge; Crislyn D'Souza-Schorey
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

10.  BU-32: a novel proteasome inhibitor for breast cancer.

Authors:  Joseph K Agyin; Bindu Santhamma; Hareesh B Nair; Sudipa S Roy; Rajeshwar R Tekmal
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.